Cargando…

CKS1 inhibition reveals vulnerabilities in leukemic stem cells with concomitant protection of healthy hematopoietic stem cells

Acute myeloid leukemia (AML) is an aggressive hematological disorder comprising a hierarchy of quiescent leukemic stem cells (LSCs) and proliferating blasts with limited self-renewal ability. AML has a dismal prognosis, with extremely low two-year survival rates in the poorest cytogenetic risk patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grey, William, Rio-Machin, Ana, Casado-Izquierdo, Pedro, Grönroos, Eva, Ali, Sara, Miettinen, Juho J., Bewicke-Copley, Findley, Parsons, Alun, Heckman, Caroline A., Swanton, Charles, Cutillas, Pedro, Gribben, John, Fitzgibbon, Jude, Bonnet, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612983/ https://www.ncbi.nlm.nih.gov/pubmed/35731890 http://dx.doi.org/10.1126/scitranslmed.abn3248

Ejemplares similares

Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes
por: Casado, Pedro, et al.
Publicado: (2023)

The CKS1/CKS2 Proteostasis Axis Is Crucial to Maintain Hematopoietic Stem Cell Function
por: Grey, William, et al.
Publicado: (2023)

Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells
por: Casado, Pedro, et al.
Publicado: (2018)

The Cks1/Cks2 axis fine-tunes Mll1 expression and is crucial for MLL-rearranged leukaemia cell viability
por: Grey, William, et al.
Publicado: (2018)

A frameshift variant in specificity protein 1 triggers superactivation of Sp1-mediated transcription in familial bone marrow failure
por: Tummala, Hemanth, et al.
Publicado: (2020)

Acquired somatic variants in inherited myeloid malignancies
por: Armes, Hannah, et al.
Publicado: (2022)

Metabolism and the leukemic stem cell
por: Abdel-Wahab, Omar, et al.
Publicado: (2010)

The role of mitochondrial proteases in leukemic cells and leukemic stem cells
por: Mirali, Sara, et al.
Publicado: (2020)

Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities
por: Marchand, Tony, et al.
Publicado: (2021)

CKS1 expression in melanocytic nevi and melanoma
por: Brożyna, Anna A., et al.
Publicado: (2017)

Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs
por: Gerdes, Henry, et al.
Publicado: (2021)

Germline ERCC excision repair 6 like 2 ( ERCC6L2 ) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironment
por: Armes, Hannah, et al.
Publicado: (2022)

Fluorouracil Selectively Enriches Stem-like Leukemic Cells in a Leukemic Cell Line
por: Zhang, Ling, et al.
Publicado: (2010)

The CDK Subunit CKS2 Counteracts CKS1 to Control Cyclin A/CDK2 Activity in Maintaining Replicative Fidelity and Neurodevelopment
por: Frontini, Mattia, et al.
Publicado: (2012)

Depletion of Cks1 and Cks2 expression compromises cell proliferation and enhance chemotherapy-induced apoptosis in HepG2 cells
por: LIN, LINGQING, et al.
Publicado: (2016)

Protracted dormancy of pre-leukemic stem cells
por: Ford, A M, et al.
Publicado: (2015)

Understanding of leukemic stem cells and their clinical implications
por: Wang, Xuefei, et al.
Publicado: (2017)

Suppression of Transposable Elements in Leukemic Stem Cells
por: Colombo, Anthony R., et al.
Publicado: (2017)

Deciphering Metabolic Adaptability of Leukemic Stem Cells
por: Patel, Sweta B., et al.
Publicado: (2022)

Frequency of Leukemic Initiating Cells does not depend on the xenotransplantation model used
por: Vargaftig, Jacques, et al.
Publicado: (2011)

Localization of SSeCKS in unmyelinated primary sensory neurons
por: Irmen, Christopher P, et al.
Publicado: (2008)

Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics
por: Velten, Lars, et al.
Publicado: (2021)

Inherited predisposition to MDS/AML
por: Rio Machin, Ana, et al.
Publicado: (2018)

Proteomic Characterization of Acute Myeloid Leukemia for Precision Medicine
por: Casado, Pedro, et al.
Publicado: (2023)

P426: HDAC INHIBITORS RESTORE SENSITIVITY TO VENETOCLAX AND NAVITOCLAX IN AML CELLS RESULTING IN THE IRREVERSIBLE DNA DAMAGE
por: Khabusheva, Elmira, et al.
Publicado: (2023)

Hypoxia factors suffocate leukemic stem cell initiation
por: Bhatia, Mick
Publicado: (2015)

Regulation of hematopoietic and leukemic stem cells by the immune system
por: Riether, C, et al.
Publicado: (2015)

Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells
por: Hemmati, Shayda, et al.
Publicado: (2017)

Cks1: Structure, Emerging Roles and Implications in Multiple Cancers
por: Khattar, Vinayak, et al.
Publicado: (2013)

Loss of cks1 homeostasis deregulates cell division cycle
por: Krishnan, Anand, et al.
Publicado: (2010)

Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen
por: Gebraad, Arjen, et al.
Publicado: (2022)

RNAi2015 – Ten years of RNAi Oxford
por: Bewicke-Copley, Findlay, et al.
Publicado: (2015)

Isolation, Maintenance and Expansion of Adult Hematopoietic Stem/Progenitor Cells and Leukemic Stem Cells
por: Mayer, Isabella Maria, et al.
Publicado: (2022)

Identification of pre-leukemic hematopoietic stem cells in acute leukemia
por: Shlush, Liran I., et al.
Publicado: (2014)

Author Correction: Suppression of Transposable Elements in Leukemic Stem Cells
por: Colombo, Anthony R., et al.
Publicado: (2018)

Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe
por: Panuzzo, Cristina, et al.
Publicado: (2020)

Leukemic Stem Cell: A Mini-Review on Clinical Perspectives
por: Barreto, Igor Valentim, et al.
Publicado: (2022)

Leukemic stem cells and therapy resistance in acute myeloid leukemia
por: Stelmach, Patrick, et al.
Publicado: (2023)

The expression of the ubiquitin ligase subunit Cks1 in human breast cancer
por: Slotky, Merav, et al.
Publicado: (2005)

Cks Overexpression Enhances Chemotherapeutic Efficacy by Overriding DNA Damage Checkpoints
por: del Rincón, Sonia V., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ltlii4539755mi6fb4mf7qurol